Liu TJ - Search Results

1

Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.

Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL. Liu TJ, et al. Cancer Gene Ther. 1999 Mar-Apr;6(2):163-71. doi: 10.1038/sj.cgt.7700007. Cancer Gene Ther. 1999. PMID: 10195883

2

HER-2/neu oncogene characterization in head and neck squamous cell carcinoma.

Beckhardt RN, Kiyokawa N, Xi L, Liu TJ, Hung MC, el-Naggar AK, Zhang HZ, Clayman GL. Beckhardt RN, et al. Among authors: liu tj. Arch Otolaryngol Head Neck Surg. 1995 Nov;121(11):1265-70. doi: 10.1001/archotol.1995.01890110041008. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7576473

3

Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.

Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Liu TJ, et al. Cancer Res. 1995 Jul 15;55(14):3117-22. Cancer Res. 1995. PMID: 7606733

4

Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation.

Janot F, el-Naggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL. Janot F, et al. Among authors: liu tj. Int J Cancer. 1995 Apr 21;64(2):117-23. doi: 10.1002/ijc.2910640208. Int J Cancer. 1995. PMID: 7615354

5

Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetration.

Clayman GL, Trapnell BC, Mittereder N, Liu TJ, Eicher S, Zhang S, Shillitoe EJ. Clayman GL, et al. Among authors: liu tj. Cancer Gene Ther. 1995 Jun;2(2):105-11. Cancer Gene Ther. 1995. PMID: 7621258

6

In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.

Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ. Clayman GL, et al. Among authors: liu tj. Cancer Res. 1995 Jan 1;55(1):1-6. Cancer Res. 1995. PMID: 7805018

7

Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.

Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Liu TJ, et al. Cancer Res. 1994 Jul 15;54(14):3662-7. Cancer Res. 1994. PMID: 8033080

8

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

Clayman GL, Liu TJ, Overholt SM, Mobley SR, Wang M, Janot F, Goepfert H. Clayman GL, et al. Among authors: liu tj. Arch Otolaryngol Head Neck Surg. 1996 May;122(5):489-93. doi: 10.1001/archotol.1996.01890170025006. Arch Otolaryngol Head Neck Surg. 1996. PMID: 8615965

9

Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.

Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MC. Hunt KK, et al. Among authors: liu tj. Cancer Res. 1997 Nov 1;57(21):4722-6. Cancer Res. 1997. PMID: 9354430

10

In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy.

Mobley SR, Liu TJ, Hudson JM, Clayman GL. Mobley SR, et al. Among authors: liu tj. Arch Otolaryngol Head Neck Surg. 1998 Jan;124(1):88-92. doi: 10.1001/archotol.124.1.88. Arch Otolaryngol Head Neck Surg. 1998. PMID: 9440786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters